Medical & Research Disclaimer

Last updated: 2026-09-22.

Retatrutide is investigational

As far as we could verify at time of publication, retatrutide is an investigational compound under clinical development and is not an approved medicine in South Africa or, to our knowledge, anywhere else. See our research overview for cited sources on its current clinical and regulatory status, which we reviewed at build time and may change after publication.

No medical advice

Nothing on Retarate is medical advice. We do not assess whether any product is safe, appropriate, or legal for any individual to use. We do not provide dosing schedules, reconstitution instructions, injection guidance, or any other information intended to facilitate human use of an unapproved product, and we will not do so on request.

No purchase facilitation

Retarate does not sell any product, does not process orders, and does not tell readers "how" or "where" to safely buy retatrutide or any peptide. Vendor review pages exist to describe what a vendor publishes and what could be independently verified about that vendor — not to recommend a purchase.

Vendor claims are not facts

Where this site describes a vendor's testing, sourcing, or safety claims, that description reflects what the vendor publishes, not an independent finding that the claim is true, unless we explicitly say we verified it and explain how.

Consult a qualified professional

If you have questions about any medicine or research compound, consult a registered medical professional or pharmacist, or contact SAHPRA for the current regulatory status of a specific product.